Yttrium-90 Radioembolization + Nivolumab for Liver + Extra-hepatic Metastases From Colorectal Cancer

NCT03307603 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Sponsor chose not to continue

Conditions

Metastatic Colorectal Cancer

Interventions

RADIATION: yttrium-90 radioembolization
DRUG: Phase Ib - nivolumab
DRUG: Phase II - nivolumab

Sponsor

Case Comprehensive Cancer Center